Merck Global Health Innovation Fund co-led the $5m equity portion of the series B round, while Silicon Valley Bank provided $3m in debt financing.
US-based healthcare IT services provider MedCPU closed an $8m series B round yesterday that included a $5m equity tranche co-led by pharmaceutical company Merck’s Global Health Innovation Fund.
Venture capital fund New Richmond Ventures co-led the equity tranche with Merck, while venture finance firm Silicon Valley Bank provided an additional $3m in debt financing.
Founded in 2009, MedCPU is the creator of a platform that analyses electronic medical records and matches them to data on best practices in order to…
